Oral Answers to Questions Debate
Full Debate: Read Full DebateGary Sambrook
Main Page: Gary Sambrook (Conservative - Birmingham, Northfield)Department Debates - View all Gary Sambrook's debates with the Department for Science, Innovation & Technology
(1 year, 6 months ago)
Commons ChamberI thank my hon. Friend, who has been a strong champion of that agenda. In the new Department’s science and technology framework we have set out a long-term, 10-year view of the serious reforms that we need to make to procurement, regulation and skills across the whole of Government if we are to drive our science superpower agenda. A fundamental part of that is converting the health of our start-up ecosystem into scale-ups. That is why the Treasury is leading on the re-regulation of pension funds—so that we can unlock some of our pension trillions and put it into supporting our companies to grow here rather than go to NASDAQ.
The UK’s life sciences sector is key to creating highly skilled jobs across the UK and cementing the UK’s role as a science superpower, as my hon. Friend the Minister for Science, Research and Innovation, a doughty champion of life sciences, has just set out. We have a life sciences vision, which sets out our ambition to develop a globally competitive investment ecosystem in the UK, and we will bring forward further measures to support the sector in the coming weeks. A great example is the life sciences investment programme, a £200 million initiative that is expected to attract at least double that in private investment.
Post pandemic, there has been a significant advance in attracting new pharma to the United Kingdom. Will the Secretary of State join me in welcoming the hugely significant partnership with Moderna as a sign of confidence in the United Kingdom? It will bring much-needed jobs and investment to the whole of the UK, and hopefully to Birmingham in particular.
Yes, I do of course join my hon. Friend in welcoming that investment. As he sets out, our goal is to ensure that the UK is the most attractive environment possible for life sciences investment, and we are doing a range of things to help achieve that. We can see exciting innovations coming into the UK as a result, including one I am very excited about that is due this year: greater personalisation in cancer drugs.
That clarification has already been made in Hansard, but there are near record numbers of people in work and in payroll. That is thanks to the actions of this Government—a record of which we are very proud.
We expect all businesses to follow the law, including providing fair pay and working conditions for their employees. We are tackling exploitation in the labour market, especially by increasing funding for enforcement bodies to more than £35 million a year, and we will continue to keep the position of hand car washes under close review.